Fermagate

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameFermagate
Drug Alias NameFermagatum铁镁加FermagatoMacrosorb MDAlpharen
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphates binders
TargetsPhosphates
Therapy Area/IndicationsKidney Failure, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[23
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIneos Healthcare Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIneos Healthcare Ltd
Active IndicationsN/A
Inactive IndicationsKidney Failure, Chronic

Other Information

ATC CodeN/A
Related LinksWikipedia